mRNA Therapeutics CDMO Market Report 2026
Download Free Sample Buy Now
mRNA Therapeutics CDMO Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

mRNA Therapeutics CDMO Market Report 2026

Global Outlook – By Type Of Service (Development Services, Manufacturing Services, Laboratory Services), By Indication (Infectious Diseases, Metabolic And Genetic Diseases, Cardiovascular And Cerebrovascular Diseases), By Application (Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies), By End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Research Organizations) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

mRNA Therapeutics CDMO Market Overview

• mRNA Therapeutics CDMO market size has reached to $4.74 billion in 2025

• Expected to grow to $8.26 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%

• Growth Driver: The Growing Burden Of Chronic And Infectious Diseases Fueling The Market Due To Increasing Therapeutic Demand

• Market Trend: Advancing mRNA Vaccines With In Situ Nanomedicine For Targeted Immunity

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under mRNA Therapeutics CDMO Market?

An mRNA therapeutics CDMO, or messenger ribonucleic acid therapeutics contract development and manufacturing organization, is a specialized third-party entity that provides end-to-end support for the research, development, and scalable production of mRNA-based therapeutic agents under contractual arrangements with pharmaceutical or biotechnology companies. These organizations play a critical role in accelerating time-to-market, ensuring regulatory compliance, and enabling flexible capacity for mRNA therapeutic pipelines.

The main types of services in the mRNA therapeutics CDMO are development services, manufacturing services, and laboratory services. Development services of mRNA therapeutics CDMO refers to the end-to-end support provided for the design, optimization, and scale-up of mRNA-based therapeutics, including synthesis, formulation, analytical development, and process development tailored to client-specific product requirements. These therapeutics are used in the indications including infectious diseases, metabolic and genetic diseases, and cardiovascular and cerebrovascular diseases in applications such as viral vaccines, protein replacement therapies, and cancer immunotherapies used by the end users, including pharmaceutical companies, biotechnology companies, academic institutions, and research organizations.

mRNA Therapeutics CDMO Market Global Report 2026 Market Report bar graph

What Is The mRNA Therapeutics CDMO Market Size and Share 2026?

The mrna therapeutics cdmo market size has grown rapidly in recent years. It will grow from $4.74 billion in 2025 to $5.31 billion in 2026 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to limited availability of specialized mrna cdmo services, reliance on in-house pharmaceutical manufacturing, growing infectious disease outbreaks, adoption of early-stage analytical testing, expansion of academic and research collaborations.

What Is The mRNA Therapeutics CDMO Market Growth Forecast?

The mrna therapeutics cdmo market size is expected to see rapid growth in the next few years. It will grow to $8.26 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to rising investment in mrna therapeutics pipelines, technological advancements in plasmid dna and mrna synthesis, growth of cancer immunotherapy and protein replacement therapies, increasing demand for fill-finish services, expansion of partnerships between biotechs and cdmos. Major trends in the forecast period include rising demand for outsourced mrna development and manufacturing, increasing focus on lipid nanoparticle (lnp) formulation technologies, expansion of viral vaccine and cancer immunotherapy pipelines, enhanced regulatory compliance and quality assurance measures, growing adoption of analytical and bioanalytical laboratory services.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global mRNA Therapeutics CDMO Market Segmentation

1) By Type Of Service: Development Services, Manufacturing Services, Laboratory Services

2) By Indication: Infectious Diseases, Metabolic And Genetic Diseases, Cardiovascular And Cerebrovascular Diseases

3) By Application: Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies

4) By End User: Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Research Organizations

Subsegments:

1) By Development Services: Process Development, Analytical Method Development, Formulation Development, Regulatory Support

2) By Manufacturing Services: Plasmid DNA Manufacturing, mRNA Synthesis, Lipid Nanoparticle (LNP) Formulation, Fill-Finish Services

3) By Laboratory Services: Quality Control Testing, Stability Testing, Bioanalytical Testing, Preclinical Testing

What Is The Driver Of The mRNA Therapeutics CDMO Market?

The growing burden of chronic and infectious diseases is expected to propel the growth of the mRNA therapeutics CDMO market going forward. Chronic and infectious diseases encompass long-term health conditions such as diabetes, cardiovascular disorders, and asthma, as well as illnesses caused by pathogenic microorganisms, including viruses, bacteria, and parasites, which can spread directly or indirectly among individuals. Chronic and infectious diseases are increasing due to aging populations, which are more susceptible to both long-term illnesses and infections. mRNA therapeutics CDMO helps address chronic and infectious diseases by providing end-to-end development and manufacturing services that accelerate the delivery of targeted, personalized mRNA therapies to patients. For instance, in October 2024, according to the World Health Organization, a Switzerland-based international public health organization, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, up from about 7.5 million in 2022, highlighting the escalating burden of infectious diseases globally. Therefore, the growing burden of chronic and infectious diseases is driving the growth of the mRNA therapeutics CDMO industry.

Key Players In The Global mRNA Therapeutics CDMO Market

Major companies operating in the mrna therapeutics cdmo market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, FUJIFILM Holdings Corporation, Evonik Industries AG, AGC Biologics GmbH, Eurofins Scientific SA, Samsung Biologics Co. Ltd., Wuxi Biologics, Recipharm AB, EMERGENT BioSolutions Inc., Genscript Biotech, Ginkgo Bioworks Holdings Inc., Corden Pharma Corp., TriLink BioTechnologies LLC, Biocina Pty Ltd., Aldevron LLC, Synbio Technologies LLC, etherna manufacturing, Bio-Synthesis Inc., Biomay AG.

Global mRNA Therapeutics CDMO Market Trends and Insights

Major companies operating in the mRNA therapeutics CDMO market are focusing on developing innovative solutions, such as in situ nanomedicine vaccines, to enhance the effectiveness and precision of mRNA-based vaccines through targeted immune stimulation. An in situ nanomedicine vaccine is a next-generation mRNA-based therapeutic designed to generate nanomedicines within the patient’s body, enabling targeted delivery and customized immune activation through engineered transgene expression. For instance, in January 2025, Esphera SynBio Inc., a Canada-based biotechnology company, launched a new project supported by the CQDM Quantum Leap program. The initiative aims to enhance first-generation lipid nanoparticle or messenger RNA (LNP/mRNA) vaccines by incorporating proprietary transgene designs that induce in vivo production of immunostimulatory nanomedicines. This approach enables precise antigen delivery and tailored immune responses, positioning the technology as a potential breakthrough in vaccine innovation.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The mRNA Therapeutics CDMO Market?

In September 2024, Agilent Technologies Inc., a US-based medical equipment company, acquired BIOVECTRA for $0.925 billion. This deal aims to expand Agilent’s CDMO capabilities into high-growth modalities, including mRNA therapeutics, by adding BIOVECTRA’s expertise in biologics and advanced pharmaceutical manufacturing. BIOVECTRA is a Canada-based contract development and manufacturing organization specializing in mRNA therapeutics and other modalities.

Regional Insights

North America was the largest region in the mRNA therapeutics CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the mRNA Therapeutics CDMO Market?

The mRNA therapeutics CDMO market consists of revenues earned by entities by providing services such as supply chain management, cold chain logistics, quality assurance auditing, clinical trial material preparation, batch release testing, serialization, and packaging. The market value includes the value of related goods sold by the service provider or included within the service offering. The mRNA therapeutics CDMO market also includes sales of products such as lipid excipients, nucleotide reagents, capping analogs, custom RNA oligonucleotides, and modified nucleosides. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the mRNA Therapeutics CDMO Market Report 2026?

The mrna therapeutics cdmo market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mrna therapeutics cdmo industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

mRNA Therapeutics CDMO Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $5.31 billion
Revenue Forecast In 2035 $8.26 billion
Growth Rate CAGR of 12.0% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type Of Service, Indication, Application, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, FUJIFILM Holdings Corporation, Evonik Industries AG, AGC Biologics GmbH, Eurofins Scientific SA, Samsung Biologics Co. Ltd., Wuxi Biologics, Recipharm AB, EMERGENT BioSolutions Inc., Genscri
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. mRNA Therapeutics CDMO Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global mRNA Therapeutics CDMO Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. mRNA Therapeutics CDMO Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global mRNA Therapeutics CDMO Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Demand For Outsourced Mrna Development And Manufacturing

4.2.2 Increasing Focus On Lipid Nanoparticle (Lnp) Formulation Technologies

4.2.3 Expansion Of Viral Vaccine And Cancer Immunotherapy Pipelines

4.2.4 Enhanced Regulatory Compliance And Quality Assurance Measures

4.2.5 Growing Adoption Of Analytical And Bioanalytical Laboratory Services

5. mRNA Therapeutics CDMO Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotechnology Companies

5.3 Academic Institutions

5.4 Research Organizations

5.5 Contract Research Organizations (Cros)

6. mRNA Therapeutics CDMO Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global mRNA Therapeutics CDMO Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global mRNA Therapeutics CDMO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global mRNA Therapeutics CDMO Market Size, Comparisons And Growth Rate Analysis

7.3. Global mRNA Therapeutics CDMO Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global mRNA Therapeutics CDMO Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global mRNA Therapeutics CDMO Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. mRNA Therapeutics CDMO Market Segmentation

9.1. Global mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Development Services, Manufacturing Services, Laboratory Services

9.2. Global mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infectious Diseases, Metabolic And Genetic Diseases, Cardiovascular And Cerebrovascular Diseases

9.3. Global mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies

9.4. Global mRNA Therapeutics CDMO Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Research Organizations

9.5. Global mRNA Therapeutics CDMO Market, Sub-Segmentation Of Development Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Process Development, Analytical Method Development, Formulation Development, Regulatory Support

9.6. Global mRNA Therapeutics CDMO Market, Sub-Segmentation Of Manufacturing Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Plasmid DNA Manufacturing, mRNA Synthesis, Lipid Nanoparticle (LNP) Formulation, Fill-Finish Services

9.7. Global mRNA Therapeutics CDMO Market, Sub-Segmentation Of Laboratory Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Quality Control Testing, Stability Testing, Bioanalytical Testing, Preclinical Testing

10. mRNA Therapeutics CDMO Market Regional And Country Analysis

10.1. Global mRNA Therapeutics CDMO Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global mRNA Therapeutics CDMO Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific mRNA Therapeutics CDMO Market

11.1. Asia-Pacific mRNA Therapeutics CDMO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China mRNA Therapeutics CDMO Market

12.1. China mRNA Therapeutics CDMO Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India mRNA Therapeutics CDMO Market

13.1. India mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan mRNA Therapeutics CDMO Market

14.1. Japan mRNA Therapeutics CDMO Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia mRNA Therapeutics CDMO Market

15.1. Australia mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia mRNA Therapeutics CDMO Market

16.1. Indonesia mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea mRNA Therapeutics CDMO Market

17.1. South Korea mRNA Therapeutics CDMO Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan mRNA Therapeutics CDMO Market

18.1. Taiwan mRNA Therapeutics CDMO Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia mRNA Therapeutics CDMO Market

19.1. South East Asia mRNA Therapeutics CDMO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe mRNA Therapeutics CDMO Market

20.1. Western Europe mRNA Therapeutics CDMO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK mRNA Therapeutics CDMO Market

21.1. UK mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany mRNA Therapeutics CDMO Market

22.1. Germany mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France mRNA Therapeutics CDMO Market

23.1. France mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy mRNA Therapeutics CDMO Market

24.1. Italy mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain mRNA Therapeutics CDMO Market

25.1. Spain mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe mRNA Therapeutics CDMO Market

26.1. Eastern Europe mRNA Therapeutics CDMO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia mRNA Therapeutics CDMO Market

27.1. Russia mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America mRNA Therapeutics CDMO Market

28.1. North America mRNA Therapeutics CDMO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA mRNA Therapeutics CDMO Market

29.1. USA mRNA Therapeutics CDMO Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada mRNA Therapeutics CDMO Market

30.1. Canada mRNA Therapeutics CDMO Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America mRNA Therapeutics CDMO Market

31.1. South America mRNA Therapeutics CDMO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil mRNA Therapeutics CDMO Market

32.1. Brazil mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East mRNA Therapeutics CDMO Market

33.1. Middle East mRNA Therapeutics CDMO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa mRNA Therapeutics CDMO Market

34.1. Africa mRNA Therapeutics CDMO Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. mRNA Therapeutics CDMO Market Regulatory and Investment Landscape

36. mRNA Therapeutics CDMO Market Competitive Landscape And Company Profiles

36.1. mRNA Therapeutics CDMO Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. mRNA Therapeutics CDMO Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. mRNA Therapeutics CDMO Market Company Profiles

36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

36.3.4. FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis

37. mRNA Therapeutics CDMO Market Other Major And Innovative Companies

AGC Biologics GmbH, Eurofins Scientific SA, Samsung Biologics Co. Ltd., Wuxi Biologics, Recipharm AB, EMERGENT BioSolutions Inc., Genscript Biotech, Ginkgo Bioworks Holdings Inc., Corden Pharma Corp., TriLink BioTechnologies LLC, Biocina Pty Ltd., Aldevron LLC, Synbio Technologies LLC, etherna manufacturing, Bio-Synthesis Inc.

38. Global mRNA Therapeutics CDMO Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The mRNA Therapeutics CDMO Market

40. mRNA Therapeutics CDMO Market High Potential Countries, Segments and Strategies

40.1 mRNA Therapeutics CDMO Market In 2030 - Countries Offering Most New Opportunities

40.2 mRNA Therapeutics CDMO Market In 2030 - Segments Offering Most New Opportunities

40.3 mRNA Therapeutics CDMO Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global mRNA Therapeutics CDMO Market, Overview Of Key Products - Product Examples
  • Table 2: Global mRNA Therapeutics CDMO Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global mRNA Therapeutics CDMO Market, Supply Chain Analysis
  • Table 4: Global mRNA Therapeutics CDMO Market, Major Raw Material Providers
  • Table 5: Global mRNA Therapeutics CDMO Market, Major Resource Providers
  • Table 6: Global mRNA Therapeutics CDMO Market, Major Manufacturers (Suppliers)
  • Table 7: Global mRNA Therapeutics CDMO Market, Major Distributors And Channel Partners
  • Table 8: Global mRNA Therapeutics CDMO Market, Key Technologies & Future Trends
  • Table 9: Global mRNA Therapeutics CDMO Market, Major Trends
  • Table 10: Global mRNA Therapeutics CDMO Market, Major End Users
  • Table 11: Global mRNA Therapeutics CDMO Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global mRNA Therapeutics CDMO Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global mRNA Therapeutics CDMO Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global mRNA Therapeutics CDMO Market - TAM, US$ Billion, 2025
  • Table 15: Global mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global mRNA Therapeutics CDMO Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global mRNA Therapeutics CDMO Market, Sub-Segmentation Of Development Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global mRNA Therapeutics CDMO Market, Sub-Segmentation Of Manufacturing Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global mRNA Therapeutics CDMO Market, Sub-Segmentation Of Laboratory Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global mRNA Therapeutics CDMO Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global mRNA Therapeutics CDMO Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global mRNA Therapeutics CDMO Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global mRNA Therapeutics CDMO Market - Company Scoring Matrix
  • Table 98: Thermo Fisher Scientific Inc. Financial Performance
  • Table 99: Danaher Corporation Financial Performance
  • Table 100: Merck KGaA Financial Performance
  • Table 101: FUJIFILM Holdings Corporation Financial Performance
  • Table 102: Evonik Industries AG Financial Performance
  • Table 103: Global mRNA Therapeutics CDMO Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global mRNA Therapeutics CDMO Market, Competitive Dashboard
  • Table 105: Global mRNA Therapeutics CDMO Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, mRNA Therapeutics CDMO Market Size Gain ($ Billion), Segmentation By Type Of Service, 2025 – 2030
  • Table 107: Global, mRNA Therapeutics CDMO Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 108: Global, mRNA Therapeutics CDMO Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global mRNA Therapeutics CDMO Market, Overview Of Key Products - Product Examples
  • Figure 2: Global mRNA Therapeutics CDMO Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global mRNA Therapeutics CDMO Market, Supply Chain Analysis
  • Figure 4: Global mRNA Therapeutics CDMO Market, Major Raw Material Providers
  • Figure 5: Global mRNA Therapeutics CDMO Market, Major Resource Providers
  • Figure 6: Global mRNA Therapeutics CDMO Market, Major Manufacturers (Suppliers)
  • Figure 7: Global mRNA Therapeutics CDMO Market, Major Distributors And Channel Partners
  • Figure 8: Global mRNA Therapeutics CDMO Market, Key Technologies & Future Trends
  • Figure 9: Global mRNA Therapeutics CDMO Market, Major Trends
  • Figure 10: Global mRNA Therapeutics CDMO Market, Major End Users
  • Figure 11: Global mRNA Therapeutics CDMO Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global mRNA Therapeutics CDMO Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global mRNA Therapeutics CDMO Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global mRNA Therapeutics CDMO Market - TAM, US$ Billion, 2025
  • Figure 15: Global mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global mRNA Therapeutics CDMO Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global mRNA Therapeutics CDMO Market, Sub-Segmentation Of Development Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global mRNA Therapeutics CDMO Market, Sub-Segmentation Of Manufacturing Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global mRNA Therapeutics CDMO Market, Sub-Segmentation Of Laboratory Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global mRNA Therapeutics CDMO Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global mRNA Therapeutics CDMO Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, mRNA Therapeutics CDMO Market, Segmentation By Type Of Service, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, mRNA Therapeutics CDMO Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, mRNA Therapeutics CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global mRNA Therapeutics CDMO Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global mRNA Therapeutics CDMO Market - Company Scoring Matrix
  • Figure 98: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 99: Danaher Corporation Financial Performance
  • Figure 100: Merck KGaA Financial Performance
  • Figure 101: FUJIFILM Holdings Corporation Financial Performance
  • Figure 102: Evonik Industries AG Financial Performance
  • Figure 103: Global mRNA Therapeutics CDMO Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global mRNA Therapeutics CDMO Market, Competitive Dashboard
  • Figure 105: Global mRNA Therapeutics CDMO Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, mRNA Therapeutics CDMO Market Size Gain ($ Billion), Segmentation By Type Of Service, 2025 – 2030
  • Figure 107: Global, mRNA Therapeutics CDMO Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 108: Global, mRNA Therapeutics CDMO Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Central Nervous System Drugs Market 2021 - By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other CNS Drugs), By Distribution Channel (Ho...

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Oncology Biosimilars Market Report 2026 - Global Outlook – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorec...

Pediatric Vaccine Market Report 2026 - Global Outlook – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, ...

Corticosteroids Market Report 2026 - Global Outlook – By Product (Glucocorticoids, Mineralocorticoids), By Application (Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applicati...

Frequently Asked Questions

The mRNA Therapeutics CDMO market was valued at $4.74 billion in 2025, increased to $5.31 billion in 2026, and is projected to reach $8.26 billion by 2030.

The global mRNA Therapeutics CDMO market is expected to grow at a CAGR of 11.7% from 2026 to 2035 to reach $8.26 billion by 2035.

Some Key Players in the mRNA Therapeutics CDMO market Include, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, FUJIFILM Holdings Corporation, Evonik Industries AG, AGC Biologics GmbH, Eurofins Scientific SA, Samsung Biologics Co. Ltd., Wuxi Biologics, Recipharm AB, EMERGENT BioSolutions Inc., Genscript Biotech, Ginkgo Bioworks Holdings Inc., Corden Pharma Corp., TriLink BioTechnologies LLC, Biocina Pty Ltd., Aldevron LLC, Synbio Technologies LLC, etherna manufacturing, Bio-Synthesis Inc., Biomay AG. .

Major trend in this market includes: Advancing mRNA Vaccines With In Situ Nanomedicine For Targeted Immunity. For further insights on this market. request a sample here

North America was the largest region in the mRNA therapeutics CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mrna therapeutics cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us